Featured Videos

“The last three years, when you look at them as a whole, were the best three years we’ve ever had,” said co-chair David Forti.        

The firms said they turned to the business consultants for advice ranging “from operational integration through to ways of working.”        

A 2020 verdict allowed Teva and other companies to produce generic versions of Vascepa. But Teva allegedly had to scale back its launch because of an inability to obtain the key ingredient, the suit said.        

“I encouraged those coming up to focus on building grit as part of their toolboxes. … Associates in 2024 are being called upon to demonstrate that grit from the jump,” writes Kate Reder Sheikh.        

This suit was surfaced by Law.com Radar, ALM’s source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign up today and be among the first to know about new suits in your region, practice area or client sector.